key: cord-1047273-sn0l9ibo
authors: Li, Jiawen; Qiu, Yu; Zhang, Yulin; Gong, Xue; He, Yunru; Yue, Peng; Zheng, Xiaolan; Liu, Lei; Liao, Hongyu; Zhou, Kaiyu; Hua, Yimin; Li, Yifei
title: Protective efficient comparisons among all kinds of respirators and masks for health-care workers against respiratory viruses: A PRISMA-compliant network meta-analysis
date: 2021-08-27
journal: Medicine (Baltimore)
DOI: 10.1097/md.0000000000027026
sha: e0941dcad2823f4b1a8bb1102ccf01e8aeb709f8
doc_id: 1047273
cord_uid: sn0l9ibo

BACKGROUND: There is no definite conclusion about comparison of better effectiveness between N95 respirators and medical masks in preventing health-care workers (HCWs) from respiratory infectious diseases, so that conflicting results and recommendations regarding the protective effects may cause difficulties for selection and compliance of respiratory personal protective equipment use for HCWs, especially facing with pandemics of corona virus disease 2019. METHODS: We systematically searched MEDLINE, Embase, PubMed, China National Knowledge Infrastructure, Wanfang, medRxiv, and Google Scholar from initiation to November 10, 2020 for randomized controlled trials, case-control studies, cohort studies, and cross-sectional studies that reported protective effects of masks or respirators for HCWs against respiratory infectious diseases. We gathered data and pooled differences in protective effects according to different types of masks, pathogens, occupations, concurrent measures, and clinical settings. The study protocol is registered with PROSPERO (registration number: 42020173279). RESULTS: We identified 4165 articles, reviewed the full text of 66 articles selected by abstracts. Six randomized clinical trials and 26 observational studies were included finally. By 2 separate conventional meta-analyses of randomized clinical trials of common respiratory viruses and observational studies of pandemic H1N1, pooled effects show no significant difference between N95 respirators and medical masks against common respiratory viruses for laboratory-confirmed respiratory virus infection (risk ratio 0.99, 95% confidence interval [CI] 0.86–1.13, I(2) = 0.0%), clinical respiratory illness (risk ratio 0.89, 95% CI 0.45–1.09, I(2) = 83.7%, P = .002), influenza-like illness (risk ratio 0.75, 95% CI 0.54–1.05, I(2) = 0.0%), and pandemic H1N1 for laboratory-confirmed respiratory virus infection (odds ratio 0.92, 95% CI 0.49–1.70, I(2) = 0.0%, P = .967). But by network meta-analysis, N95 respirators has a significantly stronger protection for HCWs from betacoronaviruses of severe acute respiratory syndrome, middle east respiratory syndrome, and corona virus disease 2019 (odds ratio 0.43, 95% CI 0.20–0.94). CONCLUSIONS: Our results provide moderate and very-low quality evidence of no significant difference between N95 respirators and medical masks for common respiratory viruses and pandemic H1N1, respectively. And we found low quality evidence that N95 respirators had a stronger protective effectiveness for HCWs against betacoronaviruses causative diseases compared to medical masks. The evidence of comparison between N95 respirators and medical masks for corona virus disease 2019 is open to question and needs further study.

Health-care workers (HCWs) are often exposed to infectious respiratory viruses transmitted by droplet, contact, or airborne mode in the medical workplace. [1] Although N95 respirators have been definitely proven to be more effective compared to medical masks in laboratory airborne and aerosols test where participants' wearing compliance was nearly perfect, [2] it is still inconclusive the same is true of the medical environment in consideration of the greater discomfort and lower adherence associated with N95 respirator use. [3] After severe acute respiratory syndrome (SARS), [4] middle east respiratory syndrome (MERS), [5] and pandemic H1N1 (pH1N1), corona virus disease 2019 (COVID- 19) , which was caused by severe acute respiratory syndrome coronavirus 2, aroused attention on respiratory personal protective equipment (rPPE) again. [6] Although World Health Organization guidelines recommend medical masks for all patient cares with the exception of N95 masks for aerosol-generating procedures, no high-quality evidence existed until 2019. A review exploring respiratory protection practices for prominent hazards in healthcare settings reported only 18% HCWs wearing a respirator for at least 1 hazard. [7] A systematic reviews and meta-analysis [8] suggested higher filtration efficiency of N95 respirators for aerosols and particles than medical mask in laboratory data. But both it and another subsequently published one [9] did not find significant different protective effects against respiratory viruses in clinical settings and put forward a strong possibility of no sufficient data to make a definite conclusion. Three randomized clinical trials (RCTs) included in mentioned meta-analyses presented insignificant superiority of N95 respirators against respiratory viruses with a broad confidence interval (CI) of the risk ratio (RR), which might mean their sample sizes were not adequate and result in the statistical underpower of conclusion of meta-analyses. [10] [11] [12] Another high quality conventional meta-analysis (CMA) revealed that face mask use could result in a large reduction in risk of infection, with stronger associations with N95 or similar respirators compared with disposable surgical masks or similar, but it did not directly compared N95 respirators with medical masks. [13] In recent years, several valued clinical trials [14] [15] [16] [17] [18] [19] [20] [21] have investigated defending effects of different masks and respirators, making it possible to increase sample sizes and improve the statistical power of meta-analyses to reach a definite conclusion. And given that COVID-19 outbreaking worldwide now, scarcity of rPPE resources, and no authoritative guideline based on highlevel evidence published, knowing appropriate selection of rPPE in different clinical setting against various microorganisms is vitally important.

We performed a systematic review and network meta-analysis (NMA) to assess and quantify protective effectiveness of N95 respirator vs medical mask against respiratory infectious viruses.

Studies included in this study satisfies inclusion criteria as followings: Populations: HCWs. Exposure: rPPE, mainly including medical masks and N95 respirators. Comparison: HCWs with no rPPE or different rPPE. Outcome: the risk of clinical or laboratory-confirmed respiratory outcomes. Study design: clinical studies including RCT, case-control study, cohort study, and cross-sectional study. Setting: health-related settings including hospital, nursing home, outpatient department, emergency department, and etc.

We excluded studies if studies were editorials, guidelines, reviews, news articles, case series, and case reports. All populations in studies were patients or community populations. Studies did not definitely state which type of rPPE was being investigated or did not report events' number of each type of rPPE.

Studies reporting on the same trial at 2 different timepoints of publication were regarded as a single trial. In addition, no studies were excluded because of high risk of bias.

RCTs and observational studies were included in 2 separate meta-analyses respectively and we would determine whether to use NMA depending on numbers of studies which did not directly compare effectiveness of N95 respirators with medical masks.

Two reviewers (Jiawen Li, Yu Qiu, and Yulin Zhang), independently and in duplicate, reviewed the titles and abstracts, and selected the studies. If 2 investigators could not resolve the disagreements through consensus, a third author (Yifei Li) would make a decision.

Data was extracted using a pre-piloted standardized data-form through PROSPERO. The primary outcome variable in this study was the incidence of laboratory-confirmed respiratory virus infection (LCV). Secondary outcomes included incidence of clinical respiratory illness, and influenza-like illness. [18] Medical masks meet bacterial and particle filtration efficiency standards, but are not certifiable as N95 respirators, which have a filtration efficiency of at least 95% against non-oily particles. Disposable masks remove very small particles from the air you breathe in but do not meet the criteria of medical mask. These particles include mircoorganisms (like viruses, bacteria, and mold) and other kinds of dust. Because of different certification of masks and respirators under public health regulation in different countries and areas, we tacitly approve that the specific rPPE type reported in articles is quantified and equivalent. Surgical mask would be recognized equal to medical mask.

All of the included RCTs and observational studies are browsed in detail for methodology relevant to potential bias. Risk of bias in RCTs was assessed by Cochrane Risk of Bias tool. [25] Risk of bias in observational studies were evaluated by Newcastle-Ottawa scales. [26] Quality of evidence of CMA and NMA is assessed according to the grading of recommendations assessment, development, and evaluation approach. [27, 28] A third author would make a judgement for the discrepancies in quality assessment where the consensus-forming discussions are difficult to make.

All outcomes were analyzed on intention-to-treat basis unless missing population covered up more than 10% of total subjects. Cluster RCTs were adjusted for its design effect by the intraclass correlation coefficient. [29] The RR and odds ratio (OR) were selected as units of dichotomous data analysis. Summary measures were pooled by fixed-effects model unless otherwise specified.

We assessed heterogeneity using the I 2 statistic and Q-test, and chose random-effects model for I 2 >50% and heterogeneity P value <.05.

For NMA, we evaluated global inconsistency by fitting both a consistency and an inconsistency model, [30] and evaluated local inconsistency between direct and indirect estimates by using a node-splitting procedure. [31] We calculated the frequentist analogue of the surface under the cumulative ranking curve for each rPPE. [32] All analyses were performed using the package Metan and Network Module in Stata statistical software (STATA, STATA15, StataCorp LLC, TX, USA) version 16.0 for Windows.

Unless otherwise specified, a two-sided P value of .05 or less was considered to indicate a statistically significant difference.

Publication bias was tested using funnel plots and the Egger test by STATA version 16.0. An asymmetric distribution of data points in the funnel plot and a quantified result of P < .05 in the Egger test indicated the presence of potential publication bias. [33] 

We performed sensitivity analysis by omitting 1 study at a time and examining the influence of each study on the pooled estimates of the primary outcome. Meanwhile, we used both random and fixed effects model to examine robustness of pooled outcome.

Pre-specified subgroup analyses included stratification by respiratory infectious diseases, study population, risk of bias, fit-testing, and other matching protective equipment if there were pooled effects with significant heterogeneity and including more than 5 studies.

A total of 4165 publications were included for further screening and from these studies, by reviewing the abstract and content, we excluded 3299 irrelevant studies. The remaining 66 studies were reviewed in detail for inclusion and exclusion criteria and 32 met the inclusion criteria (Fig. 1 ). There was no discrepancy between reviewers in the studies screening process. This process yielded 6 RCTs and 26 observational studies. Two publications of RCTs [11, 12] reported the same trial at 2 different follow-up time points. One RCT [34] was a published abridged format of another subsequent publication, [18] so we only preserved 2 [11, 18] of them for meta-analysis. The reasons why we excluded 19 observational studies were presented as followings: 7 studies were case series or case reports recognized by reading full texts [35] [36] [37] [38] [39] [40] [41] ; 3 studies did not report sufficient data to make a 2 Â 2 contingency tables (1 arm test or only reporting number of infected participants in each arm) about comparison of different masks, respirators, and control group without use or without continuous use of any type of rPPE [42] [43] [44] ; 7 studies did not state clearly and definitely the type of rPPE used (e.g., only "facemask" or "mask" mentioned in articles) [45] [46] [47] [48] [49] [50] ; 5 studies were unable to extract a number of events and participants of each arm of rPPE or their ratio (OR or RR) [43, [51] [52] [53] [54] ; individual patient data from the 32 studies including 6 RCTs and 26 observational studies were abstracted to make systemic reviews and meta-analyses, including trial characteristics, author, publication year, country, populations, interventions, outcomes, and limitations (Tables 1 and 2 ).

The risk of bias for the RCTs are summarized in Table 3 . The domain of blinding of participants and personnel are rated as high risk of bias because it is impossible to avoid recognizing the type of rPPE for both subjects and researchers. The risk of bias for observational studies is summarized in Table 4 by Newcastle-Ottawa scales.

Common respiratory viruses include influenza viruses, respiratory syncytial virus, parainfluenza viruses, and respiratory adenoviruses. Six RCTs [3, 10, 11, 18, 55, 56] including 8333 healthrelated workers (median 1064 HCWs, range 32-2668 HCWs, interquartile range [IQR] 43-1669) reported on common respiratory viruses. Across the included trials, the median age of HCWs was 36 years (range 33.1-43.0, IQR 33.6-36.1).

Women accounted for 84% (range 72%-94%, IQR 79%-90%). The median follow-up duration across studies was 55 days (range 15-97.5 days, IQR 28-84 days) in HCWs. From comparative studies between medical masks and N95 respirators for HCWs, we obtained data for 3944 (45.3%) participants of whom had been assigned to receive medical masks and 4768 (54.7%) to receive N95 respirators.

Four RCTs [3, 10, 11, 18] directly compared respiratory infection risk in HCWs wearing N95 respirators vs medical masks. Three clusters of RCTs [3, 11, 18] provided design effect and we adjusted them with individual RCTs for meta-analysis. No study reported missing data of more than 10% included participants so we extracted data from RCTs by intention-to-treat analysis. Definitions of LCV included serology [10, 18] and polymerase chain reaction, [3, 10, 11, 18] and serological criteria of infection were not suitable for participants having received vaccine.

No significant difference was detected between HCWs using N95 respirators and those using medical masks in risk of LCV (fixed-model RR 0.99, 95% CI 0.86-1.13, I 2 = 0.0%, P = .638), clinical respiratory illness (random-model RR 0.89, 95% CI 0.45-1.09, I 2 = 83.7%, P = .002), and influenza-like illness (fixed model RR 0.75, 95% CI 0.54-1.05, I 2 = 0.0%) (Fig. 2) . Although 1 RCT [18] in 2019 took up a high proportion of pooled effect, as a Table 1 Baseline characteristics of the included RCTs. : at least 1 constitutional symptom (fever, headache, and myalgia) plus at least 1 of the following local symptoms (coryza, sneezing, throat pain, cough with/ without sputum, and difficulty breathing).

: defined as having at least 2 of the following symptoms simultaneously: fever, cough, sore throat, nasal congestion, or rhinorrhea. Table 3 Cochrane risk of bias tool risk of bias for each included RCT.

RCT = randomized clinical trial. Table 4 Newcastle-Ottawa scale summary of risk of bias for cohort and case-control studies. high-quality large-scale multicenter RCT, it made no harm to the credibility of the prior conclusion in our view.

MacIntyre et al [11, 56] reported comparative analysis including cloth mask or control group and no protective effectiveness of cloth mask was found. Another RCT [55] did not report the primary and secondary outcomes mentioned above.

We did not conduct subgroup analyses because no heterogeneity of LCV (I 2 = 0.0%, P value for Q-test = .638) was detected. Fixed and random effect model come to the same conclusion except for fixed effect model of clinical respiratory illness (I 2 = 83.7%, P value for Q-test = .002) because large difference of effect size of 2 RCTs by MacIntyre et al [3] and Radonovich [18] (Fig. 2) . No meaningful publication bias and sensitivity analysis could be performed because too few RCTs were included.

In addition, 1 cohort study [57] reported that compared to HCWs who did not wear a medical mask or had poor adherence, HCWs with medical mask and better adherence had a lower rate of respiratory infection. Another case-control study [58] in Saudi Arabia suggested surgical facemasks to protect pilgrims and medical personnel should be discontinued. [59] [60] [61] (1488 patients) reported there was no significant difference between N95 respirators and medical masks in protecting HCWs from pH1N1 infection (fixed model, OR 0.93, 95% CI 0.54-1.59, I 2 = 0.0%, P = .969) (Fig. 3) . Another study [62] reported significant protective effectiveness of medical mask compared to control group without any rPPE. In view of a small number of included studies, we did not make further detection of publication bias.

Pandemic and epidemic betacoronaviruses include SARS-CoV, MERS-CoV, and SARS-CoV 2. Of the 24 eligible observational studies related to betacoronaviruses, 13 compared protective effectiveness of rPPE against SARS, including 6 cohort studies [41, [63] [64] [65] [66] [67] and 7 case-control studies [43, [68] [69] [70] [71] [72] [73] ; 4 against MERS, including 3 cohort studies [74] [75] [76] and 1 case-control study [77] ; 3 cohort studies against COVID-19, [15, 78, 79] 4 studies against pH1N1, including 1 cohort studies, [62] 1 case-control studies [61] and 2 cross-sectional studies. [59, 60] Trial sample size ranged from 9 to 5442 patients. We pooled effects of different rPPE by NMA (Fig. 4) and data for NMA was showed in Table S2 , Supplemental Digital Content, http://links.lww.com/MD2/A331. Fitness between consistency and inconsistency models, node-splitting procedure, looperspecific inconsistency estimates showed there is no significant global (chi2(6) = 7.53, P = .2750), local (Table S3 , Supplemental Digital Content, http://links.lww.com/MD2/A332) and loop ( Figure S1 , Supplemental Digital Content, http://links.lww. com/MD2/A333) inconsistency. The results provide evidence (Fig. 5 ) that there is a significant priority of N95 respirators for HCWs to prevent nosocomial infections of coronavirus causative SARS, MERS, and COVID-19 compared to medical masks (OR 0.43, 95% CI 0.20-0.94), but wide prediction interval (95% prediction interval 0.07-2.71) cross null value (1.0) reminded us of potential heterogeneity of included studies referred to N95 respirator vs medical mask. Both of them significantly bring down the secondary attack rate compared with a control group without continuous or any use of rPPE (N95 vs control, OR 0.14, 95% CI 0.07-0.28; medical vs control, OR 0.33, 95% CI 0.16-0.67). Except HCWs without any rPPE, control groups also include convenience samples of inconsistent use of rPPE or following routine infection control policies, which will mitigate the statistical difference. Although not pointing out a specific type of mask, 1 COVID-19 related study reported facemask use, especially N95 respirators or higher level rPPE, can help minimize unprotected, high-risk HCWs exposures and protect the health care workforce. [50] The analyses of paper, disposable, and cotton masks are not valuable because of a limited number of involved studies and participants. The surface under the cumulative ranking curve statistic showed that N95 respirator ranked first, followed by We adjusted the NMA by covariate of type of betacoronavirus to analyze the heterogeneity. N95 respirators still provide stronger protection than the medical masks (adjust OR 0.36, 95% CI 0.13-0.97).

The evaluation of publication bias was performed virtually using a network funnel plot for OR (Fig. 6) . As shown in Figure 6 , all the included studies were approximately symmetrically distributed around the vertical line, indicating that no significant publication bias or small sample effect exists in this network analysis.

For the pooled effect of CMA of common respiratory viruses of RCTs, and pH1N1 of observational studies, the ratings of importance and quality of evidence which we assessed using the GRADE approach [27] are summarized in Table 5 . We did not provide judgment of overall assessment because of impossible blindness of rPPE types for participants and collectors. Clusteradjusted effective sample sizes and event numbers, and no blinding of researchers, participants, and data collectors increase the risk of bias. No detection of publication bias is made because of a limited number of included studies for each evidence of CMA. Wide CIs and limited number of participants contribute imprecision of evidence.

For NMA's pooled effects of betacoronaviruses of observational studies, the evidence is assessed in Table 6 according to network GRADE method. [28] Quality of evidence for indirect estimate rated down for serious imprecision and risk of bias.

The ratings of evidence quality of common respiratory viruses of RCTs, pH1N1, and betacoronaviruses of observational studies are moderate, very low, and low, respectively.

The systematic reviews and meta-analyses are the latest update of rPPE against respiratory viruses and the first NMA of rPPE. It provides important insight into an area of medical practice that is large in scope and far-reaching. Many HCWs are exposed to patients with respiratory infectious diseases, especially COVID-19 now. Given the current interest in a more mindful approach to the use of medical resources and cost containment, understanding whether the use of N95 respirators vs medical masks affect attack rates is important because of the large difference of cost and production capacity between N95 respirators and medical masks. In CMA of common respiratory viruses, and pH1N1, compared to medical masks, N95 respirators did not provide significantly greater protection with moderate and low-quality evidence, respectively. MacIntyre et al [3, 11] reported a superior protective effect of N95 respirators against influenza and other lower incidence outcomes, which was different from the outcome of the other 2 large-scale RCTs. [10, 18] Although the evidence from CMA of RCTs is only evaluated as moderate by GRADE approach, 1 included large-scale and multicenter RCT by Radonovich et al [18] reported the same outcome as our CMA, and provided high-quality evidence with scientific and strict clinical trial design and sufficient power.

In NMA of betacoronaviruses, pooled effects provide lowquality evidence of better protective effectiveness of N95 respirators vs medical masks against SARS, MERS, and COVID-19. We also find significantly greater protectiveness of both N95 respirators and medical masks compared to HCWs without consistent use of rPPE.

All of a meta-analysis [8] and six experimental researches [19, 20, [80] [81] [82] [83] published in recent years reported N95 respirators had less filter penetration, less face-seal leakage, and less total inward leakage, compared with medical masks, under the laboratory experimental conditions, which partly explains the reasons of the priority of N95 respirators for betacoronaviruses. Conflicting outcomes of common viruses, pH1N1, and betacoronaviruses of SARS, MERS, and COVID-19, maybe due to different mode of transmission (e.g., whether to spread through aerosols or respiratory droplets) and better compliance for fatal SARS, MERS, and COVID-19, which also meant less face contamination from improper wearing or adjustment of N95 respirators.

Some studies have reported that severe acute respiratory syndrome coronavirus 2 had a household second attack rate between 3% to 10% [84] and reproduction number (R 0 ) range from 2.0 to 2.7, [85] which means its transmission mode was droplet or contact mode rather than airborne transmission. [85, 86] Therefore, N95 respirators and other particle filters did not work better than medical masks when facing with severe acute respiratory syndrome coronavirus 2 except for aerosols-generating procedures. However, America's Centres for Disease Control and Prevention recommends the use of respirators where available even for care that does not include aerosols-generating procedures. [87] Subtle differences and confounders may have existed among the studies analyzed, including details of rPPE adherence, fittesting, different levels of exposure, continuous adjustments and inappropriate wearing, influenza vaccine, concurrent interventions (e.g., gloves, gowns, safety goggles, and hand hygiene practices), and contamination of provided rPPE during storage and reuse. However, given the consistency of conclusions and low heterogeneity found in the included studies, we did not think that these potential differences affected the outcomes of our metaanalyses or the power of the overall assessment. The specific jobs and clinical departments of HCWs were mentioned by most of included studies, but nearly no individual studies provided sufficient information for a more detailed analysis.

This study has limitations as follows. None of the studies included in the meta-analysis, except 2 RCTs [10, 18] published in JAMA, independently audited compliance with the intervention. Intention-to-treat analyses in non-inferiority trials may be biased toward finding no difference and only 2 RCTs [10, 18] also conducted an analysis of LCV by per-protocol analysis, which made the same conclusions as to their corresponding intentionto-treat analyses. It is inevitable for HCWs to contact pathogens from community exposures without rPPE. Some included studies' control group consisted of HCWs following routine policies or wearing rPPE discontinuously, which would underestimate rPPE's effects. Part of asymptomatic carriers have a relatively high false negative rate of the serological tests. It is impossible to avoid bias due to lack of blinding of participants, which All studies unblinded to participants and personnel. ‡ Subtle differences of confounders may have existed among the studies, which were not reported, including details of rPPE adherence, fit-testing, continuous adjustments and inappropriate wearing, influenza vaccine, concurrent interventions (e.g., gloves, gowns, safety goggles, and hand hygiene practices), and contamination of provided rPPE during storage and reuse.

x Wide confidence interval including null value.

No testing for exposure prior to study. ¶ Limited number of events and insufficient participant numbers to detect a potential difference.

Li et al. Medicine (2021) 100:34 www.md-journal.com contributed to relatively low-GRADE quality assessment. Brands, models, or even the generic type of mask used, were often omitted. The number of studies included in the metaanalysis is limited.

This systematic review and meta-analysis showed that N95 respirators are not superior to medical masks in protecting HCWs against common respiratory viruses in clinical settings. But N95 respirators provided significantly stronger protection against betacoroviruses of SARS, MERS, and COVID-19. We recommend HCWs wear N95 respirators in the high-risk areas of betacoronaviruses and medical masks in low-risk areas. In consideration of medical ethics, it is impossible to conduct RCTs of betacoronaviruses for rPPE, more high-quality observational studies with sufficient data are needed to detect a potentially clinically important difference of N95 respirators vs medical masks for COVID-19. Given the high cost and low production capacity of N95 respirators and COVID-19 outbreaking worldwide, these findings could have a significant effect on and implications for current practice standards. CI = confidence interval, NMA = network meta-analysis, rPPE = respiratory personal protective equipment. * Quality of evidence for direct estimate rated down by 1 level for serious risk of bias. † Quality of evidence for direct estimate rated down by 1 level for serious imprecision. ‡ Quality of evidence for network estimate rated down by 1 level for serious incoherence.

x We did not downgrade for intransitivity in any of the indirect comparisons. jj All quality of evidence rated up by 1 level for large sample effect.

Infection prevention and control of epidemic and pandemic-prone acute respiratory infections in health care

Detection of infectious influenza virus in cough aerosols generated in a simulated patient examination room

A randomized clinical trial of three options for N95 respirators and medical masks in health workers

Severe acute respiratory syndrome

Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection

Risk for transportation of 2019 novel coronavirus disease from Wuhan to other cities in China

Exploring respiratory protection practices for prominent hazards in healthcare settings

Effectiveness of N95 respirators versus surgical masks in protecting health care workers from acute respiratory infection: a systematic review and meta-analysis

Effectiveness of masks and respirators against respiratory infections in healthcare workers: a systematic review and meta-analysis

Surgical mask vs N95 respirator for preventing influenza among health care workers: a randomized trial

A cluster randomized clinical trial comparing fit-tested and non-fit-tested N95 respirators to medical masks to prevent respiratory virus infection in health care workers

Efficacy of face masks and respirators in preventing upper respiratory tract bacterial colonization and co-infection in hospital healthcare workers

Physical distancing, face masks, and eye protection to prevent person-to-person transmission of SARS-CoV-2 and COVID-19: a systematic review and meta-analysis

Health care worker use of N95 respirators vs medical masks did not differ for workplace-acquired influenza

Association between 2019-nCoV transmission and N95 respirator use

Herd protection effect of N95 respirators in healthcare workers

The efficacy of medical masks and respirators against respiratory infection in healthcare workers

N95 respirators vs medical masks for preventing influenza among health care personnel: a randomized clinical trial

Assessment of influenza virus exposure and recovery from contaminated surgical masks and N95 respirators

Performance of two respiratory protective devices used by homeattending health care workers (a pilot study)

Respiratory protection of health care personnel to prevent respiratory viral transmission

Cochrane Handbook for Systematic Reviews of Interventions version 6

PRISMA GroupPreferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations

Cochrane Handbook for Systematic Reviews of Interventions (version 6)

The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses

GRADE guidelines: a new series of articles in the Journal of Clinical Epidemiology

A GRADE Working Group approach for rating the quality of treatment effect estimates from network meta-analysis

What is an intracluster correlation coefficient? Crucial concepts for primary care researchers

Consistency and inconsistency in network meta-analysis: model estimation using multivariate meta-regression

Checking consistency in mixed treatment comparison meta-analysis

Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial

The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessed

The Respiratory Protection Effectiveness Clinical Trial (ResPECT): a cluster-randomized comparison of respirator and medical mask effectiveness against respiratory infections in healthcare personnel

Transmission of pandemic (H1N1) 2009 influenza to healthcare personnel in the United States

Severe acute respiratory syndrome from the trenches, at a Singapore university hospital

Control measures for severe acute respiratory syndrome (SARS) in Taiwan

Identification and containment of an outbreak of SARS in a community hospital

Cluster of severe acute respiratory syndrome cases among protected health care workers-Toronto

Cluster of cases of severe acute respiratory syndrome among Toronto healthcare workers after implementation of infection control precautions: a case series

Lack of SARS transmission among healthcare workers, United States

Which preventive measures might protect health care workers from SARS?

A case-control study on the risk factors of severe acute respiratory syndromes among health care workers

Risk factors for SARS infection within hospitals in Hanoi, Vietnam

Infection control and SARS transmission among healthcare workers

Pandemic influenza A (H1N1) virus infection factors among healthcare workers -a case-control study

Transmission of 2009 pandemic influenza A (H1N1) virus among healthcare personnel-Southern California

Preventing healthcare workers from acquiring influenza

Factors associated with nosocomial SARS-CoV transmission among healthcare workers in Hanoi

Transmission of COVID-19 to health care personnel during exposures to a hospitalized patient

Risk of transmission via medical employees and importance of routine infection-prevention policy in a nosocomial outbreak of Middle East respiratory syndrome (MERS): a descriptive analysis from a tertiary care hospital in South Korea

Surveillance of the Middle East respiratory syndrome (MERS) coronavirus (CoV) infection in healthcare workers after contact with confirmed MERS patients: incidence and risk factors of MERS-CoV seropositivity

Lack of SARS transmission among public hospital workers

Seroprevalence of Middle East respiratory syndrome coronavirus (MERS-CoV) in public health workers responding to a MERS outbreak in Seoul, Republic of Korea

Use of surgical face masks to reduce the incidence of the common cold among health care workers in Japan: a randomized controlled trial

A cluster randomised trial of cloth masks compared with medical masks in healthcare workers

Mask-wearing and respiratory infection in healthcare workers in Beijing, China

Acute respiratory tract infections among Hajj medical mission personnel, Saudi Arabia

Seroprevalence of 2009 H1N1 virus infection and self-reported infection control practices among healthcare professionals following the first outbreak in

Seroprevalence of antibodies to pandemic (H1N1) 2009 influenza virus among health care workers in two general hospitals after first outbreak in Kobe

Factors associated with the transmission of pandemic (H1N1) 2009 among hospital healthcare workers in Beijing

Prevention of nosocomial transmission of swine-origin pandemic influenza virus A/H1N1 by infection control bundle

SARS among critical care nurses

Illness in intensive care staff after brief exposure to severe acute respiratory syndrome

Asymptomatic SARS coronavirus infection among healthcare workers

Mild illness associated with severe acute respiratory syndrome coronavirus infection: lessons from a prospective seroepidemiologic study of health-care workers in a teaching hospital in Singapore

Lack of SARS transmission and U.S. SARS case-patient

Effectiveness of precautions against droplets and contact in prevention of nosocomial transmission of severe Li et al. Medicine (2021) 100:34 www.md-journal.com acute respiratory syndrome (SARS)

Effectiveness of personal protective measures in prevention of nosocomial transmission of severe acute respiratory syndrome

Risk factors for SARS infection among hospital healthcare workers in Beijing: a case control study

Rapid awareness and transmission of severe acute respiratory syndrome in Hanoi French Hospital, Vietnam

Factors associated with transmission of severe acute respiratory syndrome among healthcare workers in Singapore

Investigation of the influencing factors on severe acute respiratory syndrome among health care workers

Risk factors for Middle East respiratory syndrome coronavirus infection among healthcare personnel

Health care worker contact with MERS patient, Saudi Arabia

Transmission among healthcare worker contacts with a Middle East respiratory syndrome patient in a single Korean centre

Factors associated with transmission of Middle East respiratory syndrome among Korean healthcare workers: infection control via extended healthcare contact management in a secondary outbreak hospital

Enhanced contact investigations for nine early travel-related cases of SARS-CoV-2 in the United States

Epidemiological characteristics of COVID-19 in medical staff members of neurosurgery departments in Hubei province: a multicentre descriptive study

How well do N95 respirators protect healthcare providers against aerosolized influenza virus?

N95 filtering facepiece respirators do not reliably afford respiratory protection during chest compression: a simulation study

Respiratory protection provided by N95 filtering facepiece respirators and disposable medicine masks against airborne bacteria in different working environments

The effect of simulated air conditions on N95 filtering facepiece respirators performance

Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19)

Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study

Use of medical face masks versus particulate respirators as a component of personal protective equipment for health care workers in the context of the COVID-19 pandemic

Centres for Disease Control and Prevention . Interim Infection Prevention and Control Recommendations for Healthcare Personnel during the Coronavirus Disease 2019 (COVID-19) Pandemic